Sign in

CIK 0001861107 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Ceribell, Inc.

Sign in to watch
Ticker
CBLL
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
471785452
Phone
(800) 436-0826
Business address
360 N. PASTORIA AVENUE, SUNNYVALE, CA, 94085
  1. 4 Planned sale President and CEO sold 25,000 shares at $16.59 ($414,750)
  2. 4 Planned sale President and CEO sold 50,000 shares at $15.13 ($756,500)
  3. 4 Planned sale Chief Technology Officer sold 11,112 shares at $12.28 ($136,455)
  4. 4 Planned sale Chief Technology Officer sold 11,112 shares at $12.54 ($139,344)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Grant or award Director acquired 25,216 shares (grant or award)
  7. 4/A Option exercise President and CEO acquired 15,928 shares (option exercise)
  8. 4/A Option exercise President and CEO acquired 9,072 shares (option exercise)
  9. 4 Planned sale Chief Technology Officer sold 11,112 shares at $12.11 ($134,566)
  10. 4 Planned sale Director sold 827 shares at $11.36 ($9,395)
  11. 4 Option exercise Chief Technology Officer acquired 20,000 shares (option exercise)
  12. 4 Open-market sale Senior VP, Finance and PAO sold 866 shares at $11.71 ($10,141)
  13. 4 Shares withheld for taxes Chief Revenue Officer gave up 660 shares (to pay taxes)
  14. 4 Shares withheld for taxes Senior VP, Finance and PAO gave up 484 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Technology Officer gave up 687 shares (to pay taxes)
  16. 4 Shares withheld for taxes President and CEO gave up 2,887 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Financial Officer gave up 687 shares (to pay taxes)
  18. 4 Open-market sale Director sold 7,032 shares at $11.76 ($82,696)
  19. 4 Planned sale President and CEO sold 25,000 shares at $17.70 ($442,500)
  20. 4 Planned sale Director sold 18,633 shares at an average $17.76 ($330,961)

Page 5 of 7 · 135 filings